Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis.
about
Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response PredictorsTreatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin.Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.Environmental assessment and exposure control of dust mites: a practice parameter.Accelerated immunotherapy schedules.Autologous immunoglobulin therapy in patients with severe recalcitrant atopic dermatitis: a preliminary report.
P2860
Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Safety of accelerated schedule ...... tients with atopic dermatitis.
@ast
Safety of accelerated schedule ...... tients with atopic dermatitis.
@en
type
label
Safety of accelerated schedule ...... tients with atopic dermatitis.
@ast
Safety of accelerated schedule ...... tients with atopic dermatitis.
@en
prefLabel
Safety of accelerated schedule ...... tients with atopic dermatitis.
@ast
Safety of accelerated schedule ...... tients with atopic dermatitis.
@en
P2093
P2860
P1476
Safety of accelerated schedule ...... atients with atopic dermatitis
@en
P2093
Gil-Soon Choi
Jeong-Eun Kim
Jin-Woo Lee
Joon-Mo Sung
Myoung-Eun Kim
P2860
P304
P356
10.3346/JKMS.2011.26.9.1159
P50
P577
2011-09-01T00:00:00Z